Cargando…
Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
A 43-year-old male with chronic Vogt–Koyanagi–Harada syndrome (VKH) presented with subfoveal choroidal neovascular membrane (CNVM) in the right eye with no evidence of active inflammation. He underwent intravitreal bevacizumab and dexamethasone injections. Postinjection he developed fresh keratic pr...
Autores principales: | Ranjan, Richa, Agarwal, Manisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989520/ https://www.ncbi.nlm.nih.gov/pubmed/29786006 http://dx.doi.org/10.4103/ijo.IJO_1145_17 |
Ejemplares similares
-
Response to comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Ranjan, Richa, et al.
Publicado: (2018) -
Comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Jain, Manish
Publicado: (2018) -
Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease
por: Byon, Ik Soo, et al.
Publicado: (2011) -
The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
por: Kolomeyer, A. M., et al.
Publicado: (2011) -
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
por: Park, Jong G., et al.
Publicado: (2020)